Skip to main content
Premium Trial:

Request an Annual Quote

Bigtime for Big Genetics

Over at Genetic Future, Daniel MacArthur writes about the promises and challenges of big genetics. This year, he writes, we'll see major data releases from several large-scale projects, including the 1,000 Genomes Project and the Cancer Genome Atlas, and disease genetics consortia such as the Wellcome Trust Case Control Consortium, GIANT, and dozens of other groups. He argues that big genetics studies will continue to lead to smaller ones, and the key point in the continuing success of big genetics is free access to the data. "Anything that interferes with open data access is a threat to the research community as a whole -- so we need to be wary both of an excessive focus on commercialisation within academia, and of well-meaning but excessive attempts to control the flow of data."

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.